SI2387563T2 - Malatna sol N-(4-((6,7-bis(metiloksi)kinolin-4-il)oksi)fenil-N'-(4-lurofenil)-ciklo- propan-1,1-dikarboksamida in njene kristalinične oblike za zdravljenje raka - Google Patents
Malatna sol N-(4-((6,7-bis(metiloksi)kinolin-4-il)oksi)fenil-N'-(4-lurofenil)-ciklo- propan-1,1-dikarboksamida in njene kristalinične oblike za zdravljenje rakaInfo
- Publication number
- SI2387563T2 SI2387563T2 SI201030193T SI201030193T SI2387563T2 SI 2387563 T2 SI2387563 T2 SI 2387563T2 SI 201030193 T SI201030193 T SI 201030193T SI 201030193 T SI201030193 T SI 201030193T SI 2387563 T2 SI2387563 T2 SI 2387563T2
- Authority
- SI
- Slovenia
- Prior art keywords
- ylćoxyćphenyl
- dicarboxamide
- methyloxy
- quinolin
- cyclopropane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14542109A | 2009-01-16 | 2009-01-16 | |
EP10701175.1A EP2387563B2 (en) | 2009-01-16 | 2010-01-15 | Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quinolin-4-yl]oxy}phenyl-n' - (4 -fluorophenyl) cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer |
PCT/US2010/021194 WO2010083414A1 (en) | 2009-01-16 | 2010-01-15 | Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quin0lin-4-yl] oxy}phenyl-n' - (4 -fluorophenyl) cyclopropane-1-dicarboxamide, and crystalline forms therof for the treatment of cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
SI2387563T1 SI2387563T1 (sl) | 2013-06-28 |
SI2387563T2 true SI2387563T2 (sl) | 2022-08-31 |
Family
ID=58449012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201030193T SI2387563T2 (sl) | 2009-01-16 | 2010-01-15 | Malatna sol N-(4-((6,7-bis(metiloksi)kinolin-4-il)oksi)fenil-N'-(4-lurofenil)-ciklo- propan-1,1-dikarboksamida in njene kristalinične oblike za zdravljenje raka |
Country Status (2)
Country | Link |
---|---|
CY (1) | CY1114007T1 (sl) |
SI (1) | SI2387563T2 (sl) |
-
2010
- 2010-01-15 SI SI201030193T patent/SI2387563T2/sl unknown
-
2013
- 2013-05-29 CY CY20131100420T patent/CY1114007T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CY1114007T1 (el) | 2016-07-27 |
SI2387563T1 (sl) | 2013-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL234097A0 (en) | Malate salt of n-(4-{[-7,6-bis(methyloxy)quinolin-4-yl]oxy}phenyl}-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for treatment in cancer | |
IL220129A (en) | History of benzamide, preparations containing them and their use in the treatment of cancer | |
IL201309A0 (en) | Novel n - (8 - heteroaryltetrahydronaphtalene - 2yl) or n - (5 - heteroarylchromane - 3 - yl) carboxamide derivatives for the treatment of pain | |
IL217768A (en) | Coinimod for the treatment of Crohn's disease | |
IL223783B (en) | Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine | |
IL216967B (en) | The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases | |
IL231495B (en) | N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide compounds or a pharmaceutically acceptable salt thereof in the preparation of a medicament for the treatment of osteoporosis | |
EP1985302A4 (en) | DRUGS FOR TUMOR THERAPY AND ITS USE | |
IL187235A0 (en) | 2,6 quinolinyl derivatives, processes for preparing them and their use as medicament | |
IL230487B (en) | 6-(n-(7-chloro-1-hydroxy-3,1-dihydrobenzo[c][1,2]oxaborole-5-yl)methylsulfonamido)-5-cyclopropyl-2-(4-fluorophenyl)-n- Methylbenzofuran-3-carboxamide, their salts and pharmaceutical preparations containing them | |
IL230484A (en) | "6- (n- (7-Chloro-1-Hydroxy-1, 3-Dihydrobenzo [c] [1,2] Oxaborol-5-Yl) - Methylbenzoforan-3 - Carbamamide and a Pharmaceutical Preparation | |
EP2328877A4 (en) | 1,4-BENZOXAZINE COMPOUNDS AND DERIVATIVES THEREOF AS THERAPEUTIC MEDICINES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
EP1881974A4 (en) | PHOSPHONE FLUOROQUINOLONES, THEIR ANTIBACTERIAL ANALOGUES, AND METHODS FOR PREVENTING AND TREATING BONE AND JOINT INFECTIONS | |
HK1164862A1 (en) | 3-benzofuranyl-indol-2-one derivatives substituted at the 3 position, preparation thereof, and therapeutic use thereof | |
SI2387563T2 (sl) | Malatna sol N-(4-((6,7-bis(metiloksi)kinolin-4-il)oksi)fenil-N'-(4-lurofenil)-ciklo- propan-1,1-dikarboksamida in njene kristalinične oblike za zdravljenje raka | |
EP2425829A4 (en) | SOLUBLE PHARMACEUTICAL FORMS OF N, N'-DIAMINODIPHENYLSULPHONE FOR OPTIMAL USE IN THE TREATMENT OF VARIOUS ILLNESSES | |
ZA201000582B (en) | 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives,preparation and therapeutic use thereof | |
HK1188565A1 (en) | Diarylpyridazinone derivatives, preparation thereof, and use thereof for the treatment of humans | |
EP2629767A4 (en) | BENZENE-SULFONANILIDE AMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND METHOD OF TREATING CANCER USING SAME | |
EP2119700A4 (en) | BENZYLAMINE DERIVATIVE OR PHARMACEUTICALLY SUBSTANTIAL ACIDIC ACID SALT AND THE USE THEREOF FOR MEDICAL PURPOSES | |
PL2521727T3 (pl) | Nowe benzoesowe pochodne pirolopirydyny i ich zastosowanie w leczeniu choroby parkinsona | |
IL214487A0 (en) | N-[(6-azabicyclo[3.2.1]oct-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof |